Before this study, our knowledge concerning the molecular features of TFE3-tRCC was limited as previous analyses contained relatively small cohorts and were mainly confined to genomic alterations11–14. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.